UNSPSC 51201826: Impromidine hydrochloride

This classification denotes an anti-lipidemic agent with the molecular formula C14H23N7S.3ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E57WP5Y41J, chemically known as guanidine, n-(3-(1h-imidazol-4-yl)propyl)-n'-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)-, trihydrochloride, but more generally known as impromidine hydrochloride, which bears US NIH Compound Identifier 163318.

European Medicines Agency schedules impromidine hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08159MIG. Most nations, for tariff purposes, schedule impromidine hydrochloride under HS 29332990. Impromidine hydrochloride bears US NLM identifiers UMLS ID C0886650 and NCI Concept Code C65903. SMILES: CC1C(NC[NH]1)CSCCNC(=N)NCCCC2C[NH]CN2.CL.CL.CL.

UNSPSC 51201826 Impromidine hydrochloride is a Commodity code that state and local procurement bodies use to classify pharmaceutical compounds, though recent activity under this specific code shows limited relevance to the taxonomy's nominal scope. The single recent opportunity recorded — a Mississippi State Department of Health sole source notice for Yellow Fever Vaccine from Sanofi Pasteur — represents a vaccine product rather than impromidine hydrochloride itself, indicating either a classification mismatch in the source record or a state procurement office applying the code more broadly than the UNSPSC taxonomy intends. State health departments appear to be the primary issuing bodies for pharmaceutical procurements under this code tier, though the sparse activity suggests this particular commodity code does not see regular competitive solicitation activity.

The recent opportunity originated in Mississippi, with a sole source objection period closing August 3, 2026. The Mississippi State Department of Health's notice allows challengers to demonstrate alternative vaccine sources; if substantiated objections are received, the department will conduct an advertised competitive process or appeal to the Public Procurement Review Board. No contract value, quantity, or term was disclosed. The mismatch between the code's pharmaceutical compound name and the vaccine procurement suggests that state and local procurement offices may be applying UNSPSC 51201826 inconsistently or that recent opportunities under this code do not reflect its intended scope. Business development professionals should verify code assignment directly with issuing bodies before committing resources to opportunities listed under this taxonomy.